H. Lundbeck AS (WBO:LUNB) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:LUNB H. Lundbeck AS WBO:LUNB
71 GF Score
Price €5.94
GF Value €6.08
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is H. Lundbeck AS Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


H. Lundbeck AS  (WBO:LUNB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


H. Lundbeck AS Cyclically Adjusted PS Ratio Related Terms


H. Lundbeck AS Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Cyclically Adjusted PS Ratio Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.14 1.44 1.78 1.80

H. Lundbeck AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.89 1.79 1.64 1.73

WBO:LUNB vs ZTS, UTHR, VTRS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Cyclically Adjusted PS Ratio falls into.


WBO:LUNB
71GF Score
H. Lundbeck AS WBO:LUNB
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

H. Lundbeck AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, H. Lundbeck AS's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.879/122.9500*122.9500
=0.879

Current CPI (Jun. 2026) = 122.9500.

H. Lundbeck AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.672 100.200 0.825
201612 0.709 100.300 0.869
201703 0.717 101.200 0.871
201706 0.728 101.200 0.884
201709 0.737 101.800 0.890
201712 0.742 101.300 0.901
201803 0.775 101.700 0.937
201806 0.794 102.300 0.954
201809 0.781 102.400 0.938
201812 0.707 102.100 0.851
201903 0.714 102.900 0.853
201906 0.715 102.900 0.854
201909 0.697 102.900 0.833
201912 0.745 102.900 0.890
202003 0.768 103.300 0.914
202006 0.737 103.200 0.878
202009 0.754 103.500 0.896
202012 0.723 103.400 0.860
202103 0.723 104.300 0.852
202106 0.670 105.000 0.785
202109 0.679 105.800 0.789
202112 0.686 106.600 0.791
202203 0.739 109.900 0.827
202206 0.605 113.600 0.655
202209 0.638 116.400 0.674
202212 0.634 115.900 0.673
202303 0.682 117.300 0.715
202306 0.668 116.400 0.706
202309 0.669 117.400 0.701
202312 0.673 116.700 0.709
202403 0.716 118.400 0.744
202406 0.740 118.500 0.768
202409 0.774 118.900 0.800
202412 0.751 118.900 0.777
202503 0.852 120.200 0.871
202506 0.802 120.700 0.817
202509 0.838 121.600 0.847
202512 0.798 121.180 0.810
202603 0.948 121.670 0.958
202606 0.879 122.950 0.879

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is H. Lundbeck AS (WBO:LUNB) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of €5.94 is trading 2.4% below its estimated GF Value™ of €6.08. GuruFocus considers H. Lundbeck AS to be Fairly Valued.

Key valuation signals for WBO:LUNB:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €6.08 vs. price of €5.94 (2.4% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the WBO:LUNB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
71GF Score

Get the complete analysis for WBO:LUNB

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.94
Price
€6.08
GF Value